Effect of anamorelin on body weight in patients with gastric cancer-associated cachexia: an observational study
Gastric Cancer · 2025
DOI: 10.1007/s10120-025-01637-3 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Gastric Cancer, 2025. Verfasst von Yoshitomo Yanagimoto und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterological Surgery, Toyonaka Municipal Hospital, Osaka, Japan. Hauptthemen laut MEDLINE: Stomach Neoplasms, Cachexia, Body Weight, Oligopeptides. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japanese Gastric Cancer Association, The University of Osaka.
Abstract (Originalsprache)
Background
In 2021, anamorelin, a ghrelin receptor agonist, was approved in Japan for cancer cachexia in select cancers, including gastric cancer. However, evidence regarding its efficacy and predictive factors in patients with gastric cancer remains lacking.
Methods
This prospective observational study encompassed 229 patients with unresectable, advanced, or recurrent gastric cancer and cancer cachexia who received anamorelin from 2021 to 2023 at 25 institutions affiliated with Osaka University. Body weight change at 12 weeks was the primary endpoint. Appetite, food intake, treatment compliance, and adverse events comprised the secondary endpoints. Multivariable logistic regression analyses were employed for identifying weight gain predictors.
Results
Of the 229 patients (median age, 73 years), 126 completed the 12-week follow-up. The median anamorelin administration duration was 62 days. The mean weight significantly increased from baseline to 4, 8, and 12 weeks (up to + 0.88 kg, p < 0.001). Moreover, appetite and food intake improved. Multivariable analysis identified baseline body mass index (BMI) < 20 kg/m 2 and neutrophil-to-lymphocyte ratio (NLR) < 4.0 as independent predictors of significant weight gain at 12 weeks. Treatment was generally well tolerated, with a 41% completion rate; 59% of the participants discontinued mainly owing to disease progression.
Conclusion
In patients with gastric cancer-related cachexia, anamorelin was associated with significant increases in body weight and improvements in appetite. Lower BMI and lower systemic inflammation (NLR < 4.0) were predictive of better response.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterological Surgery, Toyonaka Municipal Hospital, Osaka, Japan.
- Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan.
- Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita, Osaka, 565-0871, Japan. kyamashita@gesurg.med.osaka-u.ac.jp.
- Department of Gastroenterological Surgery, Sakai City Medical Center, Osaka, Japan.
- Department of Gastroenterological Surgery, Osaka International Medical and Science Center, Osaka Keisatsu Hospital, Osaka, Japan.
- Department of Gastroenterological Surgery, Osaka General Medical Center, Osaka, Japan.
Förderung
- Japanese Gastric Cancer Association
- The University of Osaka
Zitieren
APA
Yanagimoto, Y., Yamashita, K., Kawabata, R., Omori, T., Motoori, M., Nakahara, Y., Kimura, Y., Furukawa, H., Saito, T., Yamamoto, K., Takahashi, T., Kurokawa, Y., Eguchi, H., & Doki, Y. (2025). Effect of anamorelin on body weight in patients with gastric cancer-associated cachexia: an observational study. Gastric Cancer. https://doi.org/10.1007/s10120-025-01637-3
Vancouver
Yanagimoto Y, Yamashita K, Kawabata R, Omori T, Motoori M, Nakahara Y, et al. Effect of anamorelin on body weight in patients with gastric cancer-associated cachexia: an observational study. Gastric Cancer. 2025. doi:10.1007/s10120-025-01637-3
BibTeX
@article{Yanagimoto2025,
author = {Yanagimoto, Yoshitomo and Yamashita, Kotaro and Kawabata, Ryohei and Omori, Takeshi and Motoori, Masaaki and Nakahara, Yujiro and Kimura, Yutaka and Furukawa, Haruna and Saito, Takuro and Yamamoto, Kazuyoshi and Takahashi, Tsuyoshi and Kurokawa, Yukinori and Eguchi, Hidetoshi and Doki, Yuichiro},
title = {Effect of anamorelin on body weight in patients with gastric cancer-associated cachexia: an observational study},
journal = {Gastric Cancer},
year = {2025},
doi = {10.1007/s10120-025-01637-3}
}
EUVIMED